Caseware UK (AP4) 2024.0.164 2024.0.164 2025-06-30 2025-06-30 2026-05-08 1 No description of principal activity 2024-06-04 false false true The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 15759979 2024-06-03 15759979 2024-06-04 2025-06-30 15759979 2023-06-04 2024-06-03 15759979 2025-06-30 15759979 1 2024-06-04 2025-06-30 15759979 d:Director1 2024-06-04 2025-06-30 15759979 d:RegisteredOffice 2024-06-04 2025-06-30 15759979 c:CurrentFinancialInstruments 2025-06-30 15759979 c:CurrentFinancialInstruments c:WithinOneYear 2025-06-30 15759979 c:ShareCapital 2025-06-30 15759979 c:RetainedEarningsAccumulatedLosses 2025-06-30 15759979 d:OrdinaryShareClass1 2024-06-04 2025-06-30 15759979 d:OrdinaryShareClass1 2025-06-30 15759979 d:FRS102 2024-06-04 2025-06-30 15759979 d:AuditExempt-NoAccountantsReport 2024-06-04 2025-06-30 15759979 d:FullAccounts 2024-06-04 2025-06-30 15759979 d:PrivateLimitedCompanyLtd 2024-06-04 2025-06-30 15759979 e:PoundSterling 2024-06-04 2025-06-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 15759979 (England and Wales) ABG LAB UK LIMITED UNAUDITED DIRECTOR'S REPORT AND FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 JUNE 2025
ABG LAB UK LIMITED
COMPANY INFORMATION
Director | E Kuliyeva
Registered number | 15759979
Registered office | 3 Magdalene Street
| Glastonbury
| England
| BA6 9EW
ABG LAB UK LIMITED
CONTENTS
| Page
Balance Sheet | 1 - 2
Notes to the Financial Statements | 3 - 4
ABG LAB UK LIMITED REGISTERED NUMBER:15759979
BALANCE SHEET AS AT 30 JUNE 2025
|  | 2025
Note |  | £
Current assets |  |  |
Debtors: amounts falling due within one year | 3 | 850 |
Cash at bank and in hand |  | 298 |
|  | 1,148 |
Creditors: amounts falling due within one year | 4 | (10,943) |
Net current liabilities |  |  | (9,795)
Total assets less current liabilities |  |  | (9,795)
Net liabilities |  |  | (9,795)
Capital and reserves |  |  |
Called up share capital | 5 |  | 100
Profit and loss account |  |  | (9,895)
|  |  | (9,795)
Page 1
ABG LAB UK LIMITED REGISTERED NUMBER:15759979
BALANCE SHEET (CONTINUED) AS AT 30 JUNE 2025 The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006. The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime. The financial statements were approved and authorised for issue by the board and were signed on its behalf by:
E Kuliyeva
Director
Date: 8 May 2026
The notes on pages 3 to 4 form part of these financial statements. Page 2
ABG LAB UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 JUNE 2025 1.Accounting policies
| 1.1 | Basis of preparation of financial statements
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view. The financial statements are the first statutory accounts of the Company and cover the period from incorporation on 4 June 2024 to 30 June 2025. The following principal accounting policies have been applied:
| 1.2 | Going concern
The financial statements have been prepared on a going concern basis. The director considers that the company is expected to continue in operational existence and meet its liabilities as they fall due for at least twelve months from the date of approval of the financial statements. Accordingly, the going concern basis has been adopted.
| 1.3 | Debtors
Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.
| 1.4 | Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.
| 1.5 | Creditors
Short-term creditors are measured at the transaction price. Amounts due to group undertakings are intercompany loans measured at cost. These loans are unsecured, interest free and repayable on demand.
2. | Employees
| The Company has no employees other than the director, who did not receive any remuneration.
Page 3
ABG LAB UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 JUNE 2025
3. | Debtors
|  |  |  |  | 2025
|  |  |  |  | £
| Other debtors | 850
4. | Creditors: Amounts falling due within one year
|  |  |  |  | 2025
|  |  |  |  | £
| Trade creditors | 5,100
| Amounts owed to group undertakings | 243
| Accruals and deferred income | 5,600
|  | 10,943
5. | Share capital
|  |  |  |  | 2025
|  |  |  |  | £
|  | Allotted, called up and fully paid |
|  | 100 Ordinary shares of £1.00 each | 100
On incorporation, the company issued 100 ordinary shares of £1 each at par value. The shares were unpaid at the year end, and the outstanding amount of £100 is recognised within debtors.
6. | Controlling party
The Company is a wholly owned subsidiary of ABG Lab Europe Holdings LLC, which is the parent undertaking of the smallest group for which consolidated financial statements are drawn up, of which the Company is a member. The registered office of ABG Lab Europe Holdings LLC is 160 Greentree Drive, Suite 101, Dover, Delaware 19904, United States of America.
7. | Post balance sheet events
There were no adjusting events occuring between the end of the reporting period and the date these financial statements were approved.
Page 4